Results 321 to 330 of about 1,080,358 (387)
Atrial natiuretic peptid in normal humans: Hemodynamic and renal effects after single and repeated bolus injection [PDF]
Ball, P.+8 more
core
The ABDOPOCUS‐HF trial is a randomized, single‐blind, low‐intervention clinical trial (n = 168) investigating the utility of intra‐abdominal pressure (IAP) and point of care ultrasound to guide decongestive therapies during the first 72 hours after admission for acute heart failure.
C. Josa‐Laorden+20 more
wiley +1 more source
Circulating CD19 B cell counts negatively correlated with myocardial injury. CD19 B cell count was an independent predictor for all‐cause mortality and HF‐related events, but not other lymphocyte subsets. Circulating CD19 B cell counts correlated to myocardial injury and could be a feasible marker for clinical outcomes in patients with HF.
Yuta Kobayashi+11 more
wiley +1 more source
Clinical Importance of B-Type Natriuretic Peptide Levels in Sinus Rhythm at 3 Months After Persistent Atrial Fibrillation Ablation. [PDF]
Saito J+9 more
europepmc +1 more source
Abstract Background European Society of Cardiology (ESC) chronic heart failure (HF) guidelines recommend a single N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) threshold of ≥125 pg/mL for specialist referral in symptomatic patients; however, natriuretic peptide levels increase with age.
Clare J. Taylor+5 more
wiley +1 more source
N-terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome.
Nicoli CD+6 more
europepmc +1 more source
B-type natriuretic peptide efficacy compared to fragmented QRS for diastolic dysfunction screening in patients with type 2 diabetes. [PDF]
Yagi K+10 more
europepmc +1 more source
Abstract Aims Dapagliflozin, a sodium‐glucose cotransporter 2 (SGLT2) inhibitor, has shown clinical benefits in adults with heart failure (HF), improving cardiac function, reducing HF‐related hospitalizations and enhancing survival rates. While extensively studied in adult HF, data on its efficacy and safety in paediatric HF patients remain limited. We
Lisa‐Maria Rosenthal+5 more
wiley +1 more source